Global Breast Biopsy
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Breast Biopsy market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Breast Biopsy market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Product Type Segment Analysis | Vacuum Assisted biopsy, Core Needle Biopsy, Fine Needle Biopsy, Liquid Based Biopsy |
| Technology Segment Analysis | MRI guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, CT guided Biopsy, other Image-Guided Breast Biopsy |
| End-user Segment Analysis | Hospital and clinics, Diagnostic centers |
|---|---|
| Application Segment Analysis | cancer screening, Therapy selection, Treatment Monitoring |
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Breast Biopsy Market Report 2025.
As per Cognitive Market Research's latest published report, The Global Breast Biopsy market revenues were estimated to be USD $ 2.33 billion in 2021 and it is expected to reach USD $ 4.01 billion by 2030, Rising at a Compound Annual Growth Rate of 7.34% during the forecast period of 2023-2030.
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Breast Biopsy Market Sales Revenue | $ 2.33 Billion | xxxx | xxxx | 7.34% |
Breast Biopsy Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
A biopsy is an experiment in which a small bit of tissue is taken and examined in a lab. Breast tissue may be taken out for a breast biopsy using a specialized biopsy needle or it might be taken out surgically. It is examined to see if there are any abnormal cells, such as cancer cells in the body. The location and size of the breast lump will determine the type of breast biopsy surgery will be used in the hospitals. The Types of breast biopsy include fine needle aspiration, core needle aspiration, vacuum-assisted core biopsy, and ultrasound-guided biopsy. Owing to the growing number of cancer patients,the breast biopsy market is rising. The risks associated with surgical procedures will probably have adverse effects on the market for breast biopsy devices. Women are therefore advised to seek a second opinion before having any such surgical treatments, which is anticipated to have a detrimental impact on market growth.
The advancements in treatment procedures are driving the breast biopsy market's growth.
The rapidly growing advancement in breast cancer treatment procedures in recent years. There have been a number of advancements in the methods used to treat breast cancer. Such developments that have been demonstrated to improve patient outcomes include the creation of targeted medicines and immunotherapies. Furthermore, advancements in conventional treatment techniques like surgery, radiation therapy, and chemotherapy are fueling the expansion of the global market for breast biopsies. The demand for advanced techniques such as image-guided biopsies, ultrasound, MRI- guided biopsies, rising breast tomosynthesis adoption, core needle biopsies demand, and liquid biopsy demand all contribute to the market expansion.
The high risk of infection with the use of biopsy needle devices restricts the market growth. Radiologists and surgeons are establishing needle techniques such as core needles and fine needles or biopsies in examining abnormalities at a particular site. Unfortunately, aspiration and biopsy needles are frequently reused, increasing the risk of infection at the time of operations.Due to decrease in reuse of needles, the market for biopsy needles for breast cancer is facing a declining phase. Clinical issues in needle biopsy and increasing complaints of breast cancer screening methods are challenging the biopsy needles market in the forecast period of 2023-2030.
The pandemic of COVID-19 has a negative impact on market growth. The healthcare sector was immensely impacted by the prevalence of pandemic. owing to lockdowns all over the world to prevent the spread of COVID19, hospital service,clinics,diagnostic facilities were unable to deliver biopsy services.Due to lockdown and social distancing restriction many challenges are faced by the market,such as disruption in supply chain demand, technology obstacles,these challenges affected the sale of the breast biopsy devices and limited the market expansion.the restriction were likely to be reduced which helped the market to grow at a substantial pace.
We have various report editions of Breast Biopsy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.
They developed the minimally invasive blood test for the detection of an active breast cancer signature- in the earliest stages when it is easier to treat. The test evaluates gene expression patterns of 12 unique biomarkers through a custom qPCR process using proprietary software that includes machine learning -derived algorithms.
Neogenomics launched RADAR liquid biopsy test for molecular/minimal residual disease (MRD) referring to the very small number of cancer cells which may remain in the body during or after treatment. The test is available to order for breast, colorectal, lung, head and neck cancer.
Top Companies Market Share in Breast Biopsy Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Hologic | xxxx | xxxx | xxxx | xxxx |
| Becton | xxxx | xxxx | xxxx | xxxx |
| Danaher Corporation | xxxx | xxxx | xxxx | xxxx |
| Argar Medical | xxxx | xxxx | xxxx | xxxx |
| Biocept Inc. | xxxx | xxxx | xxxx | xxxx |
| Bio-Rad Laboratory | xxxx | xxxx | xxxx | xxxx |
| Hoffman-La Roche Ltd | xxxx | xxxx | xxxx | xxxx |
| Intact Medical | xxxx | xxxx | xxxx | xxxx |
| DTR Medical | xxxx | xxxx | xxxx | xxxx |
| UK biopsy | xxxx | xxxx | xxxx | xxxx |
| Ethicon endo-surgery | xxxx | xxxx | xxxx | xxxx |
| Biomed Diagnostic inc | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Based on the region, the global breast biopsy market is segmented on the basis of North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. The growth of the breast biopsy market is highest in North America. It has high market penetration for the vacuum-assisted breast biopsy market and rising demand for disposable products. Furthermore, Asia Pacific is expected to experience fast growth over the forecast period from 2023-2030. Major developed countries like the US, Canada, Italy, India, China, Japan are propelling the growth of the market.
The current report Scope analyzes Breast Biopsy Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Breast Biopsy Market is witnessing significant growth in the near future.
In 2023, the Vacuum Assisted biopsy segment accounted for noticeable share of global Breast Biopsy Market and is projected to experience significant growth in the near future.
The MRI guided Breast Biopsy segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Hologic , Danaher Corporation and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Research Analyst
LinkedIn | Profile | Book Appointment
Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.
Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Breast Biopsy Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Breast Biopsy Industry growth. Breast Biopsy market has been segmented with the help of its Product Type, Technology End-user, and others. Breast Biopsy market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Based on the product type, the global breast biopsy market is segmented on the basis of vacuum-assisted biopsy, core needle biopsy, and fine needle aspiration biopsy, under product type segment vacuum-assisted biopsy are the fastest growing market segment, as a result of the largest share of global market in 2022. These devices accurately locate the abnormality area without any difficulties which has contributed to the development of more accurate and minimally invasive treatments for the early detection of breast cancer.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Breast Biopsy Industry. Request a Free Sample PDF!
Based on the technology, the global breast biopsy market is segmented on the basis of MRI-guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, CT guided Biopsy, and Other Image-guided Breast biopsies. The ultrasound-guided biopsy market is expected to grow in the upcoming years. Due to the rising need for the detection of cancer, technology is also increasing, and ultrasound-guided biopsy delivers many advantages. This technology helps to avoid the need for ionizing radiation exposure. High efficiency, accuracy, throughputs, and low invasiveness are all these advantages that fuel the growth of the market.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Based on the end user the global breast biopsy market is segmented on the basis of hospitals, clinics, and diagnostic centers. Hospitals are the faster-growing segments of this market in the upcoming years. Hospitals control 50-60% market share for the breast biopsy market of the reimbursement policy and availability of medical instruments. The number of surgeries performed in hospitals will rise due to the high prevalence of cancer patients which will grow the demand and use of breast biopsy equipment.
Disclaimer:
| Product Type | Vacuum Assisted biopsy, Core Needle Biopsy, Fine Needle Biopsy, Liquid Based Biopsy |
| Technology | MRI guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, CT guided Biopsy, other Image-Guided Breast Biopsy |
| End-user | Hospital and clinics, Diagnostic centers |
| Application | cancer screening, Therapy selection, Treatment Monitoring |
| List of Competitors | Hologic, Becton, Danaher Corporation, Argar Medical, Biocept Inc., Bio-Rad Laboratory, Hoffman-La Roche Ltd, Intact Medical, DTR Medical, UK biopsy, Ethicon endo-surgery, Biomed Diagnostic inc |
Chapter 1 2026 Geopolitical Outlook - Breast Biopsy Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Breast Biopsy. Further deep in this chapter, you will be able to review Global Breast Biopsy Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Breast Biopsy. Further deep in this chapter, you will be able to review North America Breast Biopsy Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Breast Biopsy. Further deep in this chapter, you will be able to review Europe Breast Biopsy Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Breast Biopsy. Further deep in this chapter, you will be able to review Asia Pacific Breast Biopsy Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Breast Biopsy. Further deep in this chapter, you will be able to review South America Breast Biopsy Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Breast Biopsy. Further deep in this chapter, you will be able to review Middle East Breast Biopsy Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Breast Biopsy. Further deep in this chapter, you will be able to review Middle East Breast Biopsy Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Breast Biopsy. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Type Analysis 2019 -2031, will provide market size split by Product Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Type Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Technology Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End-user Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 15 Market Split by Application Analysis 2022 - 2034
Chapter 16 Breast Biopsy Price Trend Analysis
Chapter 17 Breast Biopsy Import/Export Analysis
Chapter 18 Breast Biopsy Production Analysis
Chapter 19 Gap Analysis
Chapter 20 Strategy Analysis
Chapter 21 Profitability and Gross Margin Analysis
Chapter 22 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Breast Biopsy market
Chapter 23 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 24 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.
A biopsy is a device that refers to utilizing medical devices or a surgical device that removes a piece of a sample or tissue of a cell, from the body in order to analyze in the laboratory for the presence of disease.